The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Raskin G.A.

Dr. Berezin Medical Institute;
Saint-Petersburg State University

Mukhina M.S.

Dr. Berezin Medical Institute

Kaurtseva A.S.

Dr. Berezin Medical Institute

Andreeva Yu.Yu.

Russian Medical Academy of Continuous Professional Education

Zavalishina L.E.

Russian Medical Academy of Continuous Professional Education

Protasova A.E.

Saint Petersburg State University;
I.I. Mechnikov North-Western State Medical University of the Ministry of Health of Russia;
OOO «AVA-PETER»;
D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology;
V.A. Almazov National Medical Research Center of the Ministry of Health of Russia

Orlova R.V.

Saint-Petersburg State University;
Saint Petersburg City Clinical Oncology Dispensary

Microsatellite instability and DNA mismatch repair deficiency detection in tumors of various sites

Authors:

Raskin G.A., Mukhina M.S., Kaurtseva A.S., Andreeva Yu.Yu., Zavalishina L.E., Protasova A.E., Orlova R.V.

More about the authors

Read: 10078 times


To cite this article:

Raskin GA, Mukhina MS, Kaurtseva AS, Andreeva YuYu, Zavalishina LE, Protasova AE, Orlova RV. Microsatellite instability and DNA mismatch repair deficiency detection in tumors of various sites. Russian Journal of Archive of Pathology. 2023;85(1):36‑42. (In Russ.)
https://doi.org/10.17116/patol20238501136

Recommended articles:
Cardiac myxoma: biological features, morphology, differential diagnosis. Russian Journal of Archive of Pathology. 2024;(6):74-81
Quality control of immu­nohistochemical studies: compulsory duty or urgent need?. Russian Journal of Archive of Pathology. 2025;(2):43-52
Soli­tary fibrous tumor of the kidney. Russian Journal of Archive of Pathology. 2025;(3):77-81
Differential Diagnosis of Perianal Skin Neoplasms. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(6):673-678
Clinical Case of HIV-Associated Kaposi’s Sarcoma. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(6):782-786

References:

  1. An JY, Kim H, Cheong JH, Hyung WJ, Kim H, Noh SH. Microsatellite instability in sporadic gastric cancer: its prognostic role and guidance for 5-FU based chemotherapy after R0 resection. Int J Cancer. 2012;131(2):505-511.  https://doi.org/10.1002/ijc.26399
  2. Smyth EC, Wotherspoon A, Peckitt C, Gonzalez D, Hulkki-Wilson S, Eltahir Z, Fassan M, Rugge M, Valeri N, Okines A, et al. Mismatch repair deficiency, microsatellite instability, and survival: an exploratory analysis of the medical research council adjuvant gastric infusional chemotherapy (MAGIC) trial. JAMA Oncol. 2017;3(9):1197-1203. https://doi.org/10.1001/jamaoncol.2016.6762
  3. Ratti M, Lampis A, Hahne JC, Passalacqua R, Valeri N. Microsatellite instability in gastric cancer: molecular bases, clinical perspectives, and new treatment approaches. Cell Mol Life Sci. 2018;75(22):4151-4162. https://doi.org/10.1007/s00018-018-2906-9
  4. Lindor NM, Burgart LJ, Leontovich O, Goldberg RM, Cunningham JM, Sargent DJ, Walsh-Vockley C, Petersen GM, Walsh MD, Leggett BA, et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol. 2002;20(4):1043-1048. https://doi.org/10.1200/JCO.2002.20.4.1043
  5. Luchini C, Bibeau F, Ligtenberg MJL, Singh N, Nottegar A, Bosse T, Miller R, Riaz N, Douillard JY, Andre F, et al. ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach. Ann Oncol. 2019;30(8):1232-1243. https://doi.org/10.1093/annonc/mdz116
  6. Choi YY, Kim H, Shin SJ, Kim HY, Lee J, Yang HK, Kim WH, Kim YW, Kook MC, Park YK, et al. Microsatellite instability and programmed cell death-ligand 1 expression in stage II/III gastric cancer: post hoc analysis of the CLASSIC randomized controlled study. Ann Surg. 2019;270(2):309-316.  https://doi.org/10.1097/SLA.0000000000002803
  7. Janjigian YY, Sanchez-Vega F, Jonsson P, Chatila WK, Hechtman JF, Ku GY, Riches JC, Tuvy Y, Kundra R, Bouvier N, et al. Genetic predictors of response to systemic therapy in esophagogastric cancer. Cancer Discov. 2018;8(1):49-58.  https://doi.org/10.1158/2159-8290.CD-17-0787
  8. Le DT, Durham JN, Smith KN, Wang H, Bartlett BR, Aulakh LK, Lu S, Kemberling H, Wilt C, Luber BS, et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science. 2017;357(6349):409-413.  https://doi.org/10.1126/science.aan6733
  9. Stelloo E, Jansen AML, Osse EM, Nout RA, Creutzberg CL, Ruano D, Church DN, Morreau H, Smit VTHBM, van Wezel T, et al. Practical guidance for mismatch repair-deficiency testing in endometrial cancer. Ann Oncol. 2017;28(1):96-102.  https://doi.org/10.1093/annonc/mdw542
  10. Bruegl AS, Ring KL, Daniels M, Fellman BM, Urbauer DL, Broaddus RR. Clinical challenges associated with universal screening for Lynch syndrome-associated endometrial cancer. Cancer Prev Res (Phila). 2017;10(2):108-115.  https://doi.org/10.1158/1940-6207.CAPR-16-0219

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.